Massive tech M&A deals are ticking up but remain subdued
Despite signs of recovery, “risk-off” tech buyers are still more wary of making large acquisitions ($100M+) than they were historically.
Despite signs of recovery, “risk-off” tech buyers are still more wary of making large acquisitions ($100M+) than they were historically.
Tech M&A buyers in Europe were behind nearly half of the world’s cross-border deals in Q2'23.
After an extended drop, buyers started to pay more per employee in tech M&A deals in Q2’23. However, they are still paying significantly less than they did in 2021.
After 2 quarters in the red, institutionally backed M&A targets are now exiting at stronger prices than their previous valuations.
In 2022, Flexport raised $935M at a valuation of $8B from an all-star group of investors including Andreessen Horowitz (a16z), MSD Partners, DST Global, Founders Fund, Shopify Ventures, and SoftBank.
The economic and regulatory climate has brought big tech M&A activity to a near halt, with acquisitions reaching an 18-quarter low in Q2’23.
Europe has led global tech M&A since surpassing the US in Q1’22. However, the US is still the undisputed champion of M&A deals worth $100M+.
Strategic tech M&A deals have tumbled by 30% since peaking in Q4’21. However, acquisitions by strategic buyers still account for more than 90% of M&A transaction activity.
Global tech M&A deal volume falls to its lowest level since 2020's Covid lockdowns as risk-off strategic acquirers pull back.
Despite a quarterly funding decline, AI sees upticks in deal count, unicorn births, and $100M+ mega-rounds in Q2'23.
The reset in private tech company valuations continued in Q2’23, especially at later stages. We look at how valuations, deal sizes, and deal terms are changing across the venture landscape.
Global corporate venture capital-backed funding ticks up for the first time in nearly 2 years.
Funding rises while deals continue to decline in Q2'23.
Funding and deals to companies in the MENA region continue to trend down in Q2’23.
The Insurtech 50 is CB Insights' annual list of the 50 most promising private insurtech companies in the world. This year’s winners are working on cyber insurance, climate risk, distribution, and more.
Global digital health funding ticks down to $3.4B, its lowest quarterly level since Q3’17.
The global fintech ecosystem slows down in Q2’23, with funding and deals falling to levels not seen since 2017.
We use CB Insights data to reveal Google Ventures' most trusted investor network — from Y Combinator to ARCH Venture Partners — that invest before, with, and after GV.
Following a slight spike last quarter, global venture funding in Q2'23 falls to its lowest level since 2020.
We use CB Insights data to break down Y Combinator’s vast investor network — including Soma Capital and Pioneer Fund — to see who’s investing before, with, and after YC the most.
We identify the AWS Generative AI Accelerator’s top priorities across healthcare, education, finance, and more.
We identify Y Combinator’s top manufacturing priorities across factory analytics, warehouse tech, and more.
The AI 100 is CB Insights' annual list of the 100 most promising private AI companies in the world. This year’s winners are working on generative AI infrastructure, emotion analytics, general-purpose humanoids, and more.
From Y Combinator to Coinbase Ventures, we use CB Insights data to break down Andreessen Horowitz’s investor network and how it might change moving forward.
Andreessen Horowitz has shifted its digital health investment strategy to focus on earlier-stage deals. We look at where it has placed its recent bets.
Over 20,000 founders applied to Y Combinator's Winter 2023 cohort. We analyze the 20 healthcare companies that made the cut.